Literature DB >> 22150647

A policy impact analysis of the mandatory NCAA sickle cell trait screening program.

Beth A Tarini1, Margaret Alison Brooks, David G Bundy.   

Abstract

OBJECTIVE: To estimate the impact of the mandatory National Collegiate Athletic Association (NCAA) sickle cell trait (SCT) screening policy on the identification of sickle cell carriers and prevention of sudden death. DATA SOURCE: We used NCAA reports, population-based SCT prevalence estimates, and published risks for exercise-related sudden death attributable to SCT. STUDY
DESIGN: We estimated the number of sickle cell carriers identified and the number of potentially preventable sudden deaths with mandatory SCT screening of NCAA Division I athletes. We calculated the number of student-athletes with SCT using a conditional probability based upon SCT prevalence data and self-identified race/ethnicity status. We estimated sudden deaths over 10 years based on published attributable risk of exercise-related sudden death due to SCT. PRINCIPAL
FINDINGS: We estimate that over 2,000 NCAA Division I student-athletes with SCT will be identified under this screening policy and that, without intervention, about seven NCAA Division I student-athletes would die suddenly as a complication of SCT over a 10-year period.
CONCLUSION: Universal sickle cell screening of NCAA Division I student-athletes will identify a substantial number of sickle cell carriers. A successful intervention could prevent about seven deaths over a decade. © Health Research and Educational Trust.

Entities:  

Mesh:

Year:  2011        PMID: 22150647      PMCID: PMC3288389          DOI: 10.1111/j.1475-6773.2011.01357.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  19 in total

1.  Comparison of electrophoresis on citrate agar, cellulose acetate, or starch for hemoglobin identification.

Authors:  E J Hicks; B J Hughes
Journal:  Clin Chem       Date:  1975-07       Impact factor: 8.327

2.  Screening student athletes for sickle cell trait--a social and clinical experiment.

Authors:  Vence L Bonham; George J Dover; Lawrence C Brody
Journal:  N Engl J Med       Date:  2010-09-09       Impact factor: 91.245

3.  Sickle cell trait in French West Indian elite sprint athletes.

Authors:  L Marlin; M Etienne-Julan; D Le Gallais; O Hue
Journal:  Int J Sports Med       Date:  2005-10       Impact factor: 3.118

Review 4.  Complications associated with sickle cell trait: a brief narrative review.

Authors:  Geoffrey Tsaras; Amma Owusu-Ansah; Freda Owusua Boateng; Yaw Amoateng-Adjepong
Journal:  Am J Med       Date:  2009-04-24       Impact factor: 4.965

5.  Sickle cell considerations in athletes.

Authors:  E Randy Eichner
Journal:  Clin Sports Med       Date:  2011-05-14       Impact factor: 2.182

6.  Sickle cell hemoglobin (Hb AS) in black football players.

Authors:  J R Murphy
Journal:  JAMA       Date:  1973-08-20       Impact factor: 56.272

7.  Some negative aspects of state health departments' policies related to screening for sickle cell anemia.

Authors:  I M Rutkow; J M Lipton
Journal:  Am J Public Health       Date:  1974-03       Impact factor: 9.308

8.  Sickle-cell programming--an imperiled promise.

Authors:  C F Whitten
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

9.  The morbidity of sickle cell trait: a review of the literature.

Authors:  D A Sears
Journal:  Am J Med       Date:  1978-06       Impact factor: 4.965

10.  Incidence of sudden cardiac death in National Collegiate Athletic Association athletes.

Authors:  Kimberly G Harmon; Irfan M Asif; David Klossner; Jonathan A Drezner
Journal:  Circulation       Date:  2011-04-04       Impact factor: 29.690

View more
  12 in total

1.  Building a bridge to somewhere better: linking health care research and health policy.

Authors:  Matthew M Davis; Cary P Gross; Carolyn M Clancy
Journal:  Health Serv Res       Date:  2012-02       Impact factor: 3.402

2.  Sickle Cell Trait Screening of Collegiate Athletes: Ethical Reasons for Program Reform.

Authors:  Rosalie Ferrari; Lisa S Parker; Robin E Grubs; Lakshmanan Krishnamurti
Journal:  J Genet Couns       Date:  2015-06-05       Impact factor: 2.537

Review 3.  Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory.

Authors:  Nigel S Key; Philippe Connes; Vimal K Derebail
Journal:  Br J Haematol       Date:  2015-03-07       Impact factor: 6.998

4.  Perspectives and Practices of Athletic Trainers and Team Physicians Implementing the 2010 NCAA Sickle Cell Trait Screening Policy.

Authors:  Mary Anne McDonald; Melissa S Creary; Jill Powell; Lori-Ann Daley; Charlotte Baker; Charmaine Dm Royal
Journal:  J Genet Couns       Date:  2017-06-03       Impact factor: 2.537

Review 5.  Pregnancy in sickle cell trait: what we do and don't know.

Authors:  Samuel Wilson; Patrick Ellsworth; Nigel S Key
Journal:  Br J Haematol       Date:  2020-02-17       Impact factor: 6.998

6.  Student-Athletes' Views on APOE Genotyping for Increased Risk of Poor Recovery after a Traumatic Brain Injury.

Authors:  Laura S Hercher; Michelle Caudle; Julie Griffin; Matthew Herzog; Diana Matviychuk; Jenna Tidwell
Journal:  J Genet Couns       Date:  2016-05-21       Impact factor: 2.537

7.  Sudden Death in High School Athletes: A Case Series Examining the Influence of Sickle Cell Trait.

Authors:  Katherine Shoush Cools; Melissa D Crowder; Kristen L Kucera; Leah C Thomas; Yuri Hosokawa; Douglas J Casa; Adil Gasim; Sang Lee; Tina M Schade Willis
Journal:  Pediatr Emerg Care       Date:  2022-02-01       Impact factor: 1.454

8.  Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIA.

Authors:  Robert I Liem; Cheeling Chan; Thanh-Huyen T Vu; Myriam Fornage; Alexis A Thompson; Kiang Liu; Mercedes R Carnethon
Journal:  Blood       Date:  2016-11-16       Impact factor: 25.476

9.  Exertional sickling: questions and controversy.

Authors:  Morey A Blinder; Sarah Russel
Journal:  Hematol Rep       Date:  2014-12-03

10.  Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening.

Authors:  Sara D Khangura; Beth K Potter; Christine Davies; Robin Ducharme; A Brianne Bota; Steven Hawken; Kumanan Wilson; Maria D Karaceper; Robert J Klaassen; Julian Little; Ewurabena Simpson; Pranesh Chakraborty
Journal:  BMC Pediatr       Date:  2021-07-01       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.